Charles Schwab’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.83M Buy
98,839
+2,307
+2% +$73.2K ﹤0.01% 2669
2026
Q1
$3.04M Buy
96,532
+15,885
+20% +$500K ﹤0.01% 2596
2025
Q4
$2.38M Buy
80,647
+17,407
+28% +$484K ﹤0.01% 2710
2025
Q3
$1.6M Buy
63,240
+8,040
+15% +$196K ﹤0.01% 2807
2025
Q2
$1.32M Buy
55,200
+41,772
+311% +$969K ﹤0.01% 2809
2025
Q1
$308K Sell
13,428
-21,438
-61% -$517K ﹤0.01% 3203
2024
Q4
$883K Buy
34,866
+14,389
+70% +$365K ﹤0.01% 2957
2024
Q3
$510K Sell
20,477
-10,340
-34% -$306K ﹤0.01% 3157
2024
Q2
$914K Buy
30,817
+14,109
+84% +$391K ﹤0.01% 2970
2024
Q1
$504K Buy
+16,708
New +$464K ﹤0.01% 3029
2023
Q4
Sell
-10,011
Closed -$371K 3563
2023
Q3
$371K Buy
10,011
+2,445
+32% +$93.4K ﹤0.01% 3156
2023
Q2
$295K Buy
+7,566
New +$296K ﹤0.01% 3235

Other funds holding RTO

Charles Schwab's RTO Position: Q2 2026 in Review

Charles Schwab increased its Rentokil (RTO) stake by 2.4% in Q2 2026, buying an estimated $73.2K and bringing the position to 98,839 shares worth $2.83M. The position accounts for ﹤0.01% of the portfolio, ranked #2669.

Charles Schwab first reported a position in RTO in Q2 2023 and has held it in 12 quarters since. The position peaked at $3.04M in Q1 2026. 283 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Charles Schwab held 98,839 shares of Rentokil worth $2.83M as of Q2 2026.
  • Charles Schwab bought 2,307 Rentokil shares in Q2 2026, an estimated $73.2K.
  • Rentokil made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2669 holding.
  • Charles Schwab first reported a position in Rentokil in Q2 2023 and has held it in 12 quarters since.
  • Charles Schwab's Rentokil position peaked at $3.04M in Q1 2026.
  • 283 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.